The Association Between Arthralgia and Vedolizumab Using Natural Language Processing.
暂无分享,去创建一个
Shawn N Murphy | Andrew Cagan | Tianrun Cai | Ashwin N Ananthakrishnan | Katherine P Liao | S. Murphy | K. Liao | A. Ananthakrishnan | T. Cai | Jie Huang | A. Cagan | Tzu-Chieh Lin | Allison Bond | Jie Huang | Gwendolyn Kane-Wanger | Tzu-Chieh Lin | A. Bond | Gwendolyn Kane-Wanger
[1] I. Kohane,et al. Improving Case Definition of Crohn's Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language Processing: A Novel Informatics Approach , 2013, Inflammatory bowel diseases.
[2] J. Jahnsen,et al. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). , 2001, Rheumatology.
[3] Sheng Yu,et al. A Short Introduction to NILE , 2013, 1311.6063.
[4] D. Jewell,et al. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history , 1998, Gut.
[5] D. M. van der Heijde,et al. The joint-gut axis in inflammatory bowel diseases. , 2010, Journal of Crohn's & colitis.
[6] M. De Vos,et al. An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series , 2016, Annals of the rheumatic diseases.
[7] A. Rizzo,et al. Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease , 2017, Annals of the rheumatic diseases.
[8] Jeffrey R Curtis,et al. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis , 2012, Arthritis care & research.
[9] H. Quan,et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.
[10] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[11] T. Stijnen,et al. Prolonged Use of Proton Pump Inhibitors, CagA Status, and the Outcome of Helicobacter pylori Gastritis , 2002, Journal of clinical gastroenterology.
[12] S. Schreiber,et al. Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study , 2016, Alimentary pharmacology & therapeutics.
[13] A. Ananthakrishnan,et al. Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort , 2015, Inflammatory bowel diseases.
[14] G. D'Haens,et al. Next-Generation Therapeutics for IBD , 2015, Current Gastroenterology Reports.
[15] Dimitrios Mitsouras,et al. Natural Language Processing Technologies in Radiology Research and Clinical Applications. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.
[16] C. Lanna,et al. A cross-sectional study of 130 Brazilian patients with Crohn’s disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations , 2008, Clinical Rheumatology.
[17] L. French,et al. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort , 2015, Inflammatory bowel diseases.